(WCH) Wacker Chemie - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: XETRA (Germany) | Market Cap: 4.164m EUR | Total Return: 14.2% in 12m

Stock Silicones, Polymers, Biosolutions, Polysilicon
Total Rating 43
Risk 83
Buy Signal -0.28
Specialty Chemicals +12.7
Specialty Chemicals +5.7
Market Cap: 4,804m
Avg Trading Vol: 10.9M EUR
ATR: 5.05%
Peers RS (IBD): 79.2
Risk 5d forecast
Volatility44.7%
Rel. Tail Risk-5.89%
Reward TTM
Sharpe Ratio0.55
Alpha8.43
Character TTM
Beta0.212
Beta Downside0.743
Drawdowns 3y
Max DD56.81%
CAGR/Max DD-0.23
EPS (Earnings per Share) EPS (Earnings per Share) of WCH over the last years for every Quarter: "2021-03": 2.06, "2021-06": 3.5, "2021-09": 4.9, "2021-12": 5.77, "2022-03": 7.92, "2022-06": 7.67, "2022-09": 5.08, "2022-12": 4.51, "2023-03": 2.9, "2023-06": 2.38, "2023-09": 0.56, "2023-12": 0.46, "2024-03": 0.89, "2024-06": 0.58, "2024-09": 0.56, "2024-12": 2.81, "2025-03": -0.16, "2025-06": -0.49, "2025-09": -1.73, "2025-12": -14.15, "2026-03": 0,
EPS CAGR: -10.83%
EPS Trend: -82.2%
Last SUE: 0.07
Qual. Beats: 0
Revenue Revenue of WCH over the last years for every Quarter: 2021-03: 1359.6, 2021-06: 1501, 2021-09: 1658.6, 2021-12: 1688.3, 2022-03: 2076.2, 2022-06: 4250.4, 2022-09: 2132.2, 2022-12: 1826.7, 2023-03: 1744, 2023-06: 1752.8, 2023-09: 1522.8, 2023-12: 1382.6, 2024-03: 1489.5, 2024-06: 1467.9, 2024-09: 1429.6, 2024-12: 1334.8, 2025-03: 1478.3, 2025-06: 1412.9, 2025-09: 1340.3, 2025-12: 1255, 2026-03: null,
Rev. CAGR: -12.56%
Rev. Trend: -76.9%
Last SUE: -0.53
Qual. Beats: 0
Risks
Technicals: choppy
Description: WCH Wacker Chemie

Wacker Chemie AG (WCH) is a German specialty chemicals company founded in 1914. It operates globally through four divisions: Silicones, Polymers, Biosolutions, and Polysilicon.

The Silicones division produces various silicone-based products. The Polymers division supplies binders and additives for construction, paper, paint, coating, and adhesive industries. The Biosolutions division offers biotech and catalog products, including pharmaceutical proteins and food additives. The Polysilicon division manufactures hyperpure polysilicon, a key material in the semiconductor industry and solar energy sector.

To further understand Wacker Chemie AGs market position and financial health, consider exploring its detailed analytics on ValueRay.

Headlines to Watch Out For
  • Polysilicon demand from solar and semiconductor industries
  • Silicones division revenue growth from construction and automotive
  • Raw material cost fluctuations impact profitability
  • Biosolutions expansion in pharmaceutical and food sectors
  • Energy prices affect production costs and margins
Piotroski VR‑10 (Strict) 2.5
Net Income: -821.1m TTM > 0 and > 6% of Revenue
FCF/TA: -0.00 > 0.02 and ΔFCF/TA 6.83 > 1.0
NWC/Revenue: 47.81% < 20% (prev 44.26%; Δ 3.55% < -1%)
CFO/TA 0.06 > 3% & CFO 542.6m > Net Income -821.1m
Net Debt (1.26b) to EBITDA (396.7m): 3.19 < 3
Current Ratio: 3.06 > 1.5 & < 3
Outstanding Shares: last quarter (49.7m) vs 12m ago -0.57% < -2%
Gross Margin: 12.00% > 18% (prev 0.17%; Δ 1.18k% > 0.5%)
Asset Turnover: 60.29% > 50% (prev 60.81%; Δ -0.52% > 0%)
Interest Coverage Ratio: -0.41 > 6 (EBITDA TTM 396.7m / Interest Expense TTM 260.0m)
Altman Z'' 3.77
A: 0.30 (Total Current Assets 3.89b - Total Current Liabilities 1.27b) / Total Assets 8.79b
B: 0.36 (Retained Earnings 3.15b / Total Assets 8.79b)
C: -0.01 (EBIT TTM -105.4m / Avg Total Assets 9.10b)
D: 0.69 (Book Value of Equity 3.49b / Total Liabilities 5.04b)
Altman-Z'' Score: 3.77 = AA
Beneish M -2.79
DSRI: 1.13 (Receivables 825.2m/764.6m, Revenue 5.49b/5.72b)
GMI: 1.44 (GM 12.00% / 17.24%)
AQI: 0.87 (AQ_t 0.16 / AQ_t-1 0.19)
SGI: 0.96 (Revenue 5.49b / 5.72b)
TATA: -0.16 (NI -821.1m - CFO 542.6m) / TA 8.79b)
Beneish M-Score: -2.79 (Cap -4..+1) = A
What is the price of WCH shares? As of April 02, 2026, the stock is trading at EUR 84.10 with a total of 141,097 shares traded.
Over the past week, the price has changed by +3.36%, over one month by +9.42%, over three months by +16.24% and over the past year by +14.23%.
Is WCH a buy, sell or hold? Wacker Chemie has no consensus analysts rating.
What are the forecasts/targets for the WCH price?
Wallstreet Target Price 73.5 -12.6%
Analysts Target Price - -
WCH Fundamental Data Overview as of 29 March 2026
Market Cap USD = 4.80b (4.16b EUR * 1.1537 EUR.USD)
P/E Forward = 21.9298
P/S = 0.7592
P/B = 1.1248
P/EG = 5.1721
Revenue TTM = 5.49b EUR
EBIT TTM = -105.4m EUR
EBITDA TTM = 396.7m EUR
Long Term Debt = 1.93b EUR (from longTermDebt, last quarter)
Short Term Debt = 161.8m EUR (from shortTermDebt, last quarter)
Debt = 2.37b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.26b EUR (from netDebt column, last quarter)
Enterprise Value = 5.05b EUR (4.16b + Debt 2.37b - CCE 1.48b)
Interest Coverage Ratio = -0.41 (Ebit TTM -105.4m / Interest Expense TTM 260.0m)
EV/FCF = -476.4x (Enterprise Value 5.05b / FCF TTM -10.6m)
FCF Yield = -0.21% (FCF TTM -10.6m / Enterprise Value 5.05b)
FCF Margin = -0.19% (FCF TTM -10.6m / Revenue TTM 5.49b)
Net Margin = -14.97% (Net Income TTM -821.1m / Revenue TTM 5.49b)
Gross Margin = 12.00% ((Revenue TTM 5.49b - Cost of Revenue TTM 4.83b) / Revenue TTM)
Gross Margin QoQ = 11.73% (prev 11.50%)
Tobins Q-Ratio = 0.57 (Enterprise Value 5.05b / Total Assets 8.79b)
Interest Expense / Debt = 5.91% (Interest Expense 140.1m / Debt 2.37b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -79.0m (EBIT -105.4m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 3.06 (Total Current Assets 3.89b / Total Current Liabilities 1.27b)
Debt / Equity = 0.66 (Debt 2.37b / totalStockholderEquity, last quarter 3.60b)
Debt / EBITDA = 3.19 (Net Debt 1.26b / EBITDA 396.7m)
 Debt / FCF = -119.3 (out of range, set to none) (Net Debt 1.26b / FCF TTM -10.6m)
 Total Stockholder Equity = 4.21b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.02% (Net Income -821.1m / Total Assets 8.79b)
RoE = -19.52% (Net Income TTM -821.1m / Total Stockholder Equity 4.21b)
RoCE = -1.72% (EBIT -105.4m / Capital Employed (Equity 4.21b + L.T.Debt 1.93b))
 RoIC = -1.68% (negative operating profit) (NOPAT -79.0m / Invested Capital 4.71b)
 WACC = 5.90% (E(4.16b)/V(6.53b) * Re(6.73%) + D(2.37b)/V(6.53b) * Rd(5.91%) * (1-Tc(0.25)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
 [DCF] Fair Price = unknown (Cash Flow -10.6m)
 EPS Correlation: -82.23 | EPS CAGR: -10.83% | SUE: 0.07 | # QB: 0
Revenue Correlation: -76.91 | Revenue CAGR: -12.56% | SUE: -0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.08 | Chg7d=+0.040 | Chg30d=+0.040 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.13 | Chg7d=+0.253 | Chg30d=-0.684 | Revisions Net=-1 | Growth EPS=+102.1% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=2.23 | Chg7d=-0.096 | Chg30d=-0.229 | Revisions Net=-3 | Growth EPS=+1579.5% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)